NorthCrest Asset Manangement’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AACR
HGIM
FI
DC
CF
NorthCrest Asset Manangement's ELV Position: Q2 2026 in Review
NorthCrest Asset Manangement reduced its Elevance Health (ELV) stake by 11% in Q2 2026, selling an estimated $51.5K and leaving 1,121 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #583.
NorthCrest Asset Manangement first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $21.6M in Q1 2022. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- NorthCrest Asset Manangement held 1,121 shares of Elevance Health worth $471K as of Q2 2026.
- NorthCrest Asset Manangement sold 139 Elevance Health shares in Q2 2026, an estimated $51.5K.
- Elevance Health made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #583 holding.
- NorthCrest Asset Manangement first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
- NorthCrest Asset Manangement's Elevance Health position peaked at $21.6M in Q1 2022.
- 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.